Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.

Dellinger RW, Santos SR, Morris M, Evans M, Alminana D, Guarente L, Marcotulli E

Open source

DOI
10.1038/s41514-017-0016-9
Published
2017
Container
NPJ aging and mechanisms of disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41514-017-0016-9,
  title = {Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.},
  author = {Dellinger RW and Santos SR and Morris M and Evans M and Alminana D and Guarente L and Marcotulli E},
  year = {2017},
  journal = {NPJ aging and mechanisms of disease},
  doi = {10.1038/s41514-017-0016-9},
  url = {https://doi.org/10.1038/s41514-017-0016-9}
}

RIS

TY  - JOUR
TI  - Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.
AU  - Dellinger RW
AU  - Santos SR
AU  - Morris M
AU  - Evans M
AU  - Alminana D
AU  - Guarente L
AU  - Marcotulli E
PY  - 2017
JO  - NPJ aging and mechanisms of disease
DO  - 10.1038/s41514-017-0016-9
UR  - https://doi.org/10.1038/s41514-017-0016-9
ER  - 

APA

RW, D., SR, S., M, M., M, E., D, A., L, G., & E, M. (2017). Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.. NPJ aging and mechanisms of disease. https://doi.org/10.1038/s41514-017-0016-9

Source records